The findings suggest that the circ-PGC/miR-532-3p/FOXR2 regulatory axis may activate the Wnt/β-catenin signaling pathway, enhancing FOXR2 expression and thus contributing to the advancement of NSCLC [34]. The gene discussed is FOXR2; the disease is non-small cell lung carcinoma.